Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer (NECI Study): a protocol for a phase II study

INTRODUCTION: The NICHE trial showed remarkable results of neoadjuvant immunotherapy in colorectal cancer patients with mismatch repair (MMR) deficiency (dMMR). However, rectal cancer patients with dMMR accounted for only 10% of case. The therapeutic effect is unsatisfactory in MMR-proficient patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yiqun, Zhu, Xiaoling, Xu, Chengcai, Ding, Caiyou, Hu, Jibo, Hong, Qiang, Wang, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016271/
https://www.ncbi.nlm.nih.gov/pubmed/36914193
http://dx.doi.org/10.1136/bmjopen-2022-069401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016271/
https://www.ncbi.nlm.nih.gov/pubmed/36914193
http://dx.doi.org/10.1136/bmjopen-2022-069401

Ejemplares similares